Same Indication

Montelukast vs Tofacitinib

Montelukast vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Montelukast and Tofacitinib.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Montelukast β€” 2.7-5.5 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Montelukast β€” C35H36ClNO3S; Tofacitinib β€” C16H20N6O.

Molecular Weight: Montelukast β€” 586.1800 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Montelukast β€” Small molecule; Tofacitinib β€” Small molecule.